Cellular Growth Kinetics Distinguish a Cyclophilin Inhibitor from an HSP90 Inhibitor as a Selective Inhibitor of Hepatitis C Virus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cellular Growth Kinetics Distinguish a Cyclophilin Inhibitor from an HSP90 Inhibitor as a Selective Inhibitor of Hepatitis C Virus

Published:2012-02-08 Issue:2 Volume:7 Page:e30286
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Beran Rudolf K. F.,Sharma Ruchi,Corsa Amoreena C.,Tian Yang,Golde Justin,Lundgaard Greta,Delaney William E.,Zhong Weidong,Greenstein Andrew E.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Therapy of hepatitis C: alpha interferon and ribavirin.;O Reichard;Hepatology,1997

2. Rapid emergence of protease inhibitor resistance in hepatitis C virus.;L Rong;Sci Transl Med,2010

3. Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance.;R Geller;Genes Dev,2007

4. Sustained virological response with 29 days of Debio 025 monotherapy in hepatitis C virus genotype 3.;H Patel;Gut,2010

5. RG7128 alone or in combination with pegylated interferon-alpha2a and ribavirin prevents hepatitis C virus (HCV) Replication and selection of resistant variants in HCV-infected patients.;S Le Pogam;J Infect Dis,2010

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory Role of Ribonucleotide Reductase Subunit M2 in Hepatocyte Growth and Pathogenesis of Hepatitis C Virus;International Journal of Molecular Sciences;2023-01-30

2. Advances in the Development of Antiviral Compounds for Rotavirus Infections;mBio;2021-05-11

3. Antiviral nucleoside analogs;Chemistry of Heterocyclic Compounds;2021-04

4. Influence of 4′-Substitution on the Activity of Gemcitabine and Its ProTide Against VZV and SARS-CoV-2;ACS Medicinal Chemistry Letters;2020-12-09

5. Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation;Antiviral Research;2020-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3